Racial Differences in Pelvic Organ Prolapse
Overview
Authors
Affiliations
Objective: To compare the estimated prevalence of, risk factors for, and level of bother associated with subjectively reported and objectively measured pelvic organ prolapse in a racially diverse cohort.
Methods: The Reproductive Risks for Incontinence Study at Kaiser 2 is a population-based cohort study of 2,270 middle-aged and older women. Symptomatic prolapse was self-reported, and bother was assessed on a five-point scale. In 1,137 women, prolapse was measured with the Pelvic Organ Prolapse Quantification (POP-Q) system. Multivariable logistic regression analysis was used to identify the independent association of prolapse and race while controlling for risk factors.
Results: The participants' mean (standard deviation) age was 55 (9) years, and 44% were white, 20% were African American, 18% were Asian American, and 18% were Latina or other race. Seventy-four women (3%) reported symptomatic prolapse. In multivariable analysis, the risk of symptomatic prolapse was higher in white (prevalence ratio 5.35, 95% confidence interval [CI] 1.89-15.12) and Latina (prevalence ratio 4.89, 95% CI 1.64-14.58) compared with African-American women. Race was not associated with report of moderate to severe bother. Degree of prolapse by POP-Q stage was similar across all racial groups; however, the risk of the leading edge of prolapse at or beyond the hymen was higher in white (prevalence ratio 1.40, 95% CI 1.02-1.92) compared with African-American women.
Conclusion: Compared with African-American women, Latina and white women had four to five times higher risk of symptomatic prolapse, and white women had 1.4-fold higher risk of objective prolapse with leading edge of prolapse at or beyond the hymen.
Level Of Evidence: II.
Investigating Racial, Ethnic, and Socioeconomic Disparities in Pelvic Organ Prolapse Surgery.
DeAndrade S, DePorto K, Crawford K, Saporito L, Nguyen A, Yazdany T Urogynecology (Phila). 2025; 31(3):174-182.
PMID: 39760186 PMC: 11902576. DOI: 10.1097/SPV.0000000000001633.
Unveiling the depths of pelvic organ prolapse: From risk factors to therapeutic methods (Review).
Gao J, Li Y, Hou J, Wang Y Exp Ther Med. 2024; 29(1):11.
PMID: 39582942 PMC: 11582525. DOI: 10.3892/etm.2024.12761.
Xie B, Nandikanti L, Swenson C, Wu J, Liu T, Yang X Int Urogynecol J. 2024; 36(2):363-371.
PMID: 39560762 DOI: 10.1007/s00192-024-05945-7.
Genetics of Female Pelvic Organ Prolapse: Up to Date.
Li Y, Li Z, Li Y, Gao X, Wang T, Huang Y Biomolecules. 2024; 14(9).
PMID: 39334862 PMC: 11430778. DOI: 10.3390/biom14091097.
Carter-Brooks C, Brown O, Ackenbom M Obstet Gynecol Clin North Am. 2024; 51(1):157-179.
PMID: 38267125 PMC: 11093648. DOI: 10.1016/j.ogc.2023.11.002.